Remdesivir use in COVID-19 patients with end-stage kidney disease on intermittent hemodialysis: An absolute contraindication?

Haddad, Issa; Agarwal, Priyal; Hassanein, Mohamed

Haddad, Issa; Agarwal, Priyal; Hassanein, Mohamed.

Haddad I; Department of Internal Medicine, Michigan State University, Lansing, MI, USA.
Agarwal P; Department of Internal Medicine, Michigan State University, Lansing, MI, USA.
Hassanein M; Department of Nephrology, University of Mississippi Medical Center, Jackson, MS, USA.

Ther Apher Dial ; 26(4): 850-851, 2022 08.

Article in English | MEDLINE | ID: covidwho-1731062

Subject(s)

COVID-19 Drug Treatment; Kidney Failure, Chronic; Adenosine Monophosphate/analogs & derivatives; Alanine/analogs & derivatives; Antiviral Agents/therapeutic use; Contraindications; Humans; Kidney Failure, Chronic/complications; Kidney Failure, Chronic/therapy; Renal Dialysis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Kidney Failure, Chronic Topics: Long Covid Limits: Humans Language: English Journal: Ther Apher Dial Journal subject: Hematology Year: 2022 Document Type: Article Affiliation country: 1744-9987.13833

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google